Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia:: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin

被引：53

作者：

Zwaan, C

Reinhardt, D

Jürgens, H

Huismans, D

Hählen, K

Smith, OP

Biondi, A

van Wering, ER

Feingold, J

Kaspers, GJL

机构：

[1] Free Univ Amsterdam, Med Ctr, Dept Pediat Hematol & Oncol, NL-1081 HV Amsterdam, Netherlands

[2] Univ Munster, Childrens Hosp, Dept Pediat Hematol & Oncol, D-4400 Munster, Germany

[3] Erasmus Univ, Sophia Childrens Hosp, Dept Pediat Oncol, Rotterdam, Netherlands

[4] Our Ladys Hosp Sick Children, Dept Paediat Haematol & Oncol, Dublin, Ireland

[5] Univ Milano Bicocca, Osped S Gerardo, Ctr M Tettamanti, Pediat Clin, Monza, Italy

[6] Dutch Childhood Leukemia Study Grp, The Hague, Netherlands

[7] Wyeth Pharmaceut, St Davids, PA USA

来源：

LEUKEMIA | 2003年 / 17卷 / 02期

关键词：

D O I：

10.1038/sj.leu.2402749

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：468 / 470

页数：3

共 6 条

[1]

Bernt KM, 2000, BLOOD, V96, p467A

[2]

HINMAN LM, 1993, CANCER RES, V53, P3336

[3]

Putti MC, 1998, BLOOD, V92, P795

[4] Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: A phase I study of an anti-CD33 calicheamicin immunoconjugate [J].

Sievers, EL ;

Appelbaum, FR ;

Spielberger, RT ;

Forman, SJ ;

Flowers, D ;

Smith, FO ;

Shannon-Dorcy, K ;

Berger, MS ;

Bernstein, ID .

BLOOD, 1999, 93 (11) :3678-3684

[5] Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse [J].

Sievers, EL ;

Larson, RA ;

Stadtmauer, EA ;

Estey, E ;

Löwenberg, B ;

Dombret, H ;

Karanes, C ;

Theobald, M ;

Bennett, JM ;

Sherman, ML ;

Berger, MS ;

Eten, CB ;

Loken, MR ;

van Dongen, JJM ;

Bernstein, ID ;

Appelbaum, FR .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3244-3254

[6]

Zwaan CM, 2000, BLOOD, V96, P2879

← 1 →